BRITTNEE BECK: Open Payments
NPI 1407546021 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 60 payments from 17 companies in 2025. Trend: 2023 $721 · 2024 $1,276 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $194 |
| Lilly USA, LLC | 14 | $183 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Amgen Inc. | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| ABBVIE INC. | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: NURTEC ODT, REXULTI, MOUNJARO, JARDIANCE, CAPLYTA, REPATHA, AIRSUPRA, Kerendia.
Industry payments across AL — which companies pay providers there.
